Certis Biologicals is a pioneer in the development of biological pesticides and has become one of the world’s leading manufacturers and distributors of biopesticides. We specialize in:

Biological product development, from screening to formulation to field development
Manufacturing: fermentation and formulation
Global registrations for biological products
Global sales channels. We export to more than 30 countries.

Certis Biologicals traces its roots to some of the early leaders in the development of biological and botanical pesticides, beginning with the formation of Thermo Trilogy in 1996 and the acquisition of Neem Technologies from W.R. Grace. Since then, the company has grown by identifying and acquiring products that complement its product line. These include baculovirus products acquired from Biosys in 1997 and Bt bioinsecticide products acquired from Novartis in 1997 and Ecogen in 2002.

In 2001, Mitsui & Co., a leading Japanese trading company, acquired Thermo Trilogy and renamed it Certis U.S.A. L.L.C. Within Mitsui's AgriScience Division, Certis Biologicals is positioned as the global competence center for biological control technologies. Today the company’s product line represents some of finest bioproducts and active ingredients in the industry.

Agriculture & Farming

Biotechnology

Manufacturing

Certis Biologicals

Certis Biologicals' headquarters in Columbia, MD, United States

Jose Carvalho

Ivan Wollenmann

Jeremy Wagnitz

Dhritiman Ghosh

Ryutaro Matsuhashi

Evonne McCabe-Brown-Sphr

Celeste W.

Gillian Dubin

Jennifer Napoli

David Silva

Jim Black

Saul Borbolla Ibarra

Gregory Rogers

Amanda Eade

Karly Regan

Stephen Pierson

Myriam Olortegui

William Devane

Brittany Nordmark

Jesus V.

Thomas van Groningen

Luis Solari

Judy Collier

Felipe Moraes

Description

People (8)

Kasia O'Donnell